Correlation Between Exelixis and Sarepta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Exelixis and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Sarepta Therapeutics, you can compare the effects of market volatilities on Exelixis and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Sarepta Therapeutics.
Diversification Opportunities for Exelixis and Sarepta Therapeutics
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Exelixis and Sarepta is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of Exelixis i.e., Exelixis and Sarepta Therapeutics go up and down completely randomly.
Pair Corralation between Exelixis and Sarepta Therapeutics
Given the investment horizon of 90 days Exelixis is expected to generate 1.11 times more return on investment than Sarepta Therapeutics. However, Exelixis is 1.11 times more volatile than Sarepta Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Sarepta Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 3,348 in Exelixis on October 23, 2024 and sell it today you would earn a total of 295.00 from holding Exelixis or generate 8.81% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Exelixis vs. Sarepta Therapeutics
Performance |
Timeline |
Exelixis |
Sarepta Therapeutics |
Exelixis and Sarepta Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Exelixis and Sarepta Therapeutics
The main advantage of trading using opposite Exelixis and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.Exelixis vs. TG Therapeutics | Exelixis vs. Viking Therapeutics | Exelixis vs. Madrigal Pharmaceuticals | Exelixis vs. BioXcel Therapeutics |
Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |